Clinical Relapse Prediction of Ulcerative Colitis Using an Endoscopy Automated Diagnosis System

Prospective study of clinical relapse prediction of ulcerative colitis using automated diagnosis system with ultra-magnification endoscope - Prospective study of clinical relapse prediction of ulcerative colitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036650

Enrollment

150

Registered

2019-05-07

Start date

2019-05-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who have been diagnosed with establised ulcerative colitis.Patients who perform colonoscopy following to their clinical needs. Patients with clinical remission (partial Mayo Score of 0 or 1).Patients not using Prednisolone within half a year.Patients who have not received radiation therapy for the abdominal or pelvis.

Exclusion criteria

Exclusion criteria: Patients who have been denied participation in this study Patients who could not follow up at the end of the study or until relapse

Design outcomes

Primary

Measure	Time frame
the difference in clinical relapse rate according to the diagnosis of UC-CAD.	—

Secondary

Measure	Time frame
1. The differences in clinical relapse rate by extent of disease according to the diagnosis according to UC-CAD 2. The differences in clinical relapse rate according to the diagnosis according to endoscopists. 3. Time required to diagnose UC-CAD 4. Cecal success rate 5. Cecal insertion success time	—

Countries

Japan

Contacts

Public ContactYasuharu Maeda

Showa University Northern Yokohama Hospital Digestive Disease Center

yasuharumaeda610@hotmail.com+81459497000

Outcome results